Posted by Steve Halasey | Dec 23, 2013 | Molecular Diagnostics |
Molecular diagnostics company CombiMatrix, Irvine, Calif, has entered into a contractual agreement for coverage of its diagnostic laboratory services with FedMed, a national provider network and healthcare financial services organization.
Read MorePosted by Steve Halasey | Dec 23, 2013 | Molecular Diagnostics, Prenatal Testing, Womens Health |
The New York State Department of Health has issued a clinical laboratory permit for Natera, of San Carlos, Calif, enabling the company to make its portfolio of preconception and prenatal tests available to expecting parents in New York State.
Read MorePosted by Jenny Lower | Dec 16, 2013 | Breast, Cancer, Molecular Diagnostics, Research |
In a recent clinical study, a hereditary cancer test from Myriad Genetics detected breast and ovarian cancer 51% more often than tests for BCRA1 or BCRA2 genes alone.
Read MorePosted by Jenny Lower | Dec 16, 2013 | Uncategorized |
Invitae Corp. has garnered $40 million in Series E financing to expand its global presence and continue development of multi-gene tests for hereditary disorders.
Read MorePosted by Steve Halasey | Dec 16, 2013 | Molecular Diagnostics |
Insight Genetics, a molecular diagnostics company focused on advancing precision medicine in cancer care, has announced the launch of Insight Molecular Labs, a CLIA-certified laboratory offering diagnostic tests that identify cancer biomarkers.
Read More